F523-0530 Screening compound: 2-[4-(1-phenyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one

F523-0530 Screening compound: 2-[4-(1-phenyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one
F523-0530 Screening compound: 2-[4-(1-phenyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F523-0530
2-[4-(1-phenyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F523-0530

Molecular Formula

C25H26N4O (C25 H26 N4 O)

Compound Name

2-[4-(1-phenyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one

IUPAC name

2-[4-(1-phenyl-1H-pyrazol-4-yl)-1236-tetrahydropyridin-1-yl]-1-(1234-tetrahydroquinolin-1-yl)ethan-1-one

SMILES

O=C(CN(CC1)CC=C1c1cn(-c2ccccc2)nc1)N(CCC1)c2c1cccc2

InChI

InChI=1S/C25H26N4O/c30-25(28-14-6-8-21-7-4-5-11-24(21)28)19-27-15-12-20(13-16-27)22-17-26-29(18-22)23-9-2-1-3-10-23/h1-5,7,9-12,17-18H,6,8,13-16,19H2

InChI Key

JPGZLRLUQLXQFG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27172134

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

398.51

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.855

Distribution Coefficient, logD

3.855

Water Solubility, LogSw

-4.00

Polar Surface Area

33.114

Acid Dissociation Constant (pKa)

23.08

Base Dissociation Constant (pKb)

2.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

F523-0530 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F523-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F523-0530?
Check Price and Availability of F523-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F523-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F523-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F523-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F523-0530 available by request